Early proteins E6 and E7 of human papillomavirus may attenuate ischemia-reperfusion injury

Medical Hypotheses

Volumn 76, Issue 4, 2011, Pages 607-609

  Sima, Ni ^a   Lü, Weiguo ^a   Xie, Xing ^a  

^a Zhejiang University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 7; COMPLEMENT COMPONENT C5 INHIBITOR; CYCLOHEXIMIDE; FERULIC ACID; LYSOPHOSPHATIDIC ACID; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; DNA FRAGMENTATION; DRUG CARCINOGENICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIA; KIDNEY INJURY; KIDNEY ISCHEMIA; NEUROPROTECTION; NONHUMAN; RENAL PROTECTION; REPERFUSION INJURY; WART VIRUS;

APOPTOSIS; DNA-BINDING PROTEINS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPERFUSION INJURY; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 79952312853     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.013     Document Type: Article

References (26)

1. zur Hausen H., Gissmann L., Steiner W., Dippold W., Dreger I. Human papilloma viruses and cancer. Bibl Haematol 1975, 569-571.
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265.
3. Lambert P.F., Pan H., Pitot H.C., Liem A., Jackson M., Griep A.E. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci USA 1993, 90:5583-5587.
4. Eefting F., Rensing B., Wigman J., et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 2004, 61:414-426.
5. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
6. Harbour J.W., Dean D.C. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000, 2:E65-E67.
7. Formigli L., Ibba-Manneschi L., Perna A.M., et al. Ischemia-reperfusion-induced apoptosis and p53 expression in the course of rat heterotopic heart transplantation. Microvasc Res 1998, 56:277-281.
8. Yu Y., Luo X., Ren Q.G., et al. The involvement of upregulation and translocation of phospho-Rb in early neuronal apoptosis following focal cerebral ischemia in rats. Neurochem Res 2009, 34:1113-1119.
9. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
10. Ikeda H., Suzuki Y., Suzuki M., et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 1998, 42:530-537.
11. Rudiger H.A., Graf R., Clavien P.A. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003, 16:149-159.
12. Suzuki C., Isaka Y., Shimizu S., et al. Bcl-2 protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting apoptosis. Cell Transplant 2008, 17:223-229.
13. Cheng C.Y., Su S.Y., Tang N.Y., Ho T.Y., Chiang S.Y., Hsieh C.L. Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 2008, 1209:136-150.
14. Zhang X., Shan P., Otterbein L.E., et al. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 2003, 278:1248-1258.
15. De Vries B., Matthijsen R.A., Wolfs T.G., Van Bijnen A.A., Heeringa P., Buurman W.A. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003, 75:375-382.
16. de Vries B., Matthijsen R.A., van Bijnen A.A., Wolfs T.G., Buurman W.A. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 2003, 163:47-56.
17. Musat-Marcu S., Gunter H.E., Jugdutt B.I., Docherty J.C. Inhibition of apoptosis after ischemia-reperfusion in rat myocardium by cycloheximide. J Mol Cell Cardiol 1999, 31:1073-1082.
18. Lopez-Neblina F., Toledo A.H., Toledo-Pereyra L.H. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 2005, 18:335-350.
19. Komarov P.G., Komarova E.A., Kondratov R.V., et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285:1733-1737.
20. Kelly K.J., Plotkin Z., Vulgamott S.L., Dagher P.C. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 2003, 14:128-138.
21. Liu P., Xu B., Cavalieri T.A., Hock C.E. Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24hours of reperfusion. Shock 2008, 30:545-551.
22. Molitoris B.A., Dagher P.C., Sandoval R.M., et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 2009, 20:1754-1764.
23. Kailong L., Du X., Yani H., et al. P53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury. Biocell 2007, 31:213-223.
24. Zhao X., Gschwend J.E., Powell C.T., Foster R.G., Day K.C., Day M.L. Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells. J Biol Chem 1997, 272:22751-22757.
25. Yugawa T., Kiyono T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 2009, 19:97-113.
26. Schiffman M., Kjaer S.K. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003, 14-19.